Cargando…
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
In patients with severe eosinophilic asthma and sputum eosinophil counts of ≥3–<30%, sputum eosinophils may not represent a more useful biomarker than blood eosinophils for predicting clinical treatment response to mepolizumab https://bit.ly/3pOTw93
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062111/ https://www.ncbi.nlm.nih.gov/pubmed/35509441 http://dx.doi.org/10.1183/23120541.00560-2021 |